We have identified a mutation in the insulin-like growth factor receptor in residue 481 of the alpha subunit (extracellular domain) in a pediatric patient with growth retardation. We have created plasmids that express the normal receptor and the mutated receptor and have transfected NIH-3T3 cells with these plasmids to obtain clones to examine the functionality of the mutation. These studies will include IGF-I binding to the receptor and the activation of the tyrosine kinase activity to determine how this mutation affects skeletal growth.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK055017-07
Application #
7152978
Study Section
(CEB)
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2005
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
United States
Zip Code